Archive position — measured, not model output
0 likes on Devpost
2,264 of the 7,856 archived projects have more likes, and 5,592 share exactly 0 — so this project's #6,287 place in the like-ranked listing is a tie-break inside that group, not a ranking.
Projects (log scale)
Likes on Devpost. ▲ marks this project's group.
Show the figures
| Likes | Projects | Share of archive |
|---|---|---|
| 0 | 5,592 | 71.2% |
| 1 | 1,758 | 22.4% |
| 2 | 285 | 3.6% |
| 3–4 | 132 | 1.7% |
| 5–9 | 75 | 1.0% |
| 10+ | 14 | 0.2% |
Executive Summary
What the company appears to be
ReClaim is a self-reported tool for researchers to review and validate claims in manuscripts against supporting code, data, and results. It operates as a private workspace that allows uploading of research projects (in ZIP format), extracts claims from text-based documents, connects them to evidence, and flags inconsistencies or missing elements.
What changed
The project was built as part of the OpenAI 2026 hackathon submission. The author describes it as a prototype with local execution capabilities, including optional integrations with LLMs like GPT-5.6 and Ollama for reviewer guidance, but no public deployment or commercial use is evidenced.
Single most important open question
Is there any evidence of real-world usage, adoption, or traction beyond the author's own development and demonstration?
What The Product Actually Is
The description states that ReClaim is a private research evidence-review workspace. It allows researchers to upload ZIP files containing manuscripts and supporting project files (code, data, figures). The system:
- Extracts claims from LaTeX, Markdown, text, and PDF manuscripts
- Inspects Python scripts and notebooks without executing them
- Reads CSV and JSON result files
- Connects claims to relevant code, data, figures, and outputs
- Detects numerical mismatches and held-out-test contradictions
- Identifies missing evidence and potential overclaims
- Evaluates claim coverage, traceability, methodology, data integrity, and reproducibility
- Converts findings into priority flags with assignees, reviewers, deadlines, and statuses
- Supports project members, comments, notifications, and version history
- Exports a structured Markdown Evidence Report
Inference ReClaim appears to be designed for internal research teams or small groups working on reproducible science. It is not described as a platform for public review or collaboration beyond the project team.
Positioning & Claim Evolution
The author states that ReClaim was inspired by a real example where a manuscript claimed one result while the actual held-out test showed another. This suggests an intent to address discrepancies between claims and evidence in research workflows.
The tool is positioned as a way to flag contradictions, number mismatches, and missing evidence before submission or publication, aiming to improve reproducibility and scientific rigor.
It also emphasizes that the readiness indicators are diagnostic—not publication-acceptance scores or substitutes for expert peer review.
Inference ReClaim positions itself as a pre-publication validation tool, not a replacement for peer review or publication approval systems.
Target Customer & ICP
The description states that ReClaim is intended for researchers and research teams who work with manuscripts, code, datasets, and figures. It supports private workspaces for collaborative correction of claims.
It targets users who are concerned about:
- Numerical consistency
- Reproducibility
- Data integrity
- Methodology traceability
Inference The ICP likely includes academic researchers, research labs, or small teams working in fields where reproducibility and evidence alignment matter (e.g., computational science, data science, experimental research).
Business Model & Pricing Evidence
There is no evidence of a business model or pricing structure. The author states that:
- The core application works locally without a paid API
- Optional bounded reviewer guidance can run privately through Gemma 3 1B using Ollama
- An optional OpenAI Responses API integration exists but remains disabled unless deliberately configured
Inference No commercial revenue or pricing model is described. It appears to be a personal or prototype project, not a scalable product with monetization.
Technical & Delivery Signals
The system is built with:
- Backend: FastAPI and Python
- Frontend: HTML, CSS, JavaScript
- Storage: SQLite (local)
- Tools used: Docker, GitHub Actions, Pydantic, pytest, responses, Ollama, OpenAI APIs, GPT-5.6, Codex
It supports:
- ZIP upload of research projects
- Text-based manuscript parsing
- Non-execution of Python code
- Secure handling of archives
- Role-based access control
- Version history tracking
- Email reminders (without credential exposure)
- Export to Markdown Evidence Report
Inference The tool is built for local execution, with no cloud or SaaS deployment mentioned. It uses open-source and proprietary tools but does not appear to be production-ready beyond a prototype.
Traction & Maturity Signals
There is no evidence of traction, customers, revenue, or adoption beyond the author’s own development and demonstration.
The project includes:
- A built-in synthetic demonstration
- 17 passing automated tests
- A repository and documentation prepared with Codex assistance
Inference No real-world usage or user feedback is reported. It is a prototype, not a product in active use.
Competitive Context
The description does not mention any competitors. However, based on the stated goals (claim validation, reproducibility, evidence alignment), ReClaim may relate to:
- Reproducible research tools
- Scientific workflow platforms
- Manuscript review and collaboration systems
- AI-assisted research validation tools
Inference No competitive landscape is described or evidenced. The tool does not appear to be part of an existing ecosystem.
Key Risks & Red Flags
- No commercial traction or adoption: The project is described as a prototype with no evidence of real-world usage.
- Local-only execution: No cloud deployment or SaaS offering is mentioned, limiting scalability.
- Self-reported tooling: All technical and product details are self-reported; no independent verification.
- No pricing or monetization model: No indication of how the tool would be monetized if scaled.
- Limited scope: The system focuses on static analysis and does not execute code, which may limit its utility in some cases.
Diligence Questions To Ask The Founders
- Has ReClaim been tested or used by any external researchers or teams?
- What is the plan for scaling beyond local execution (e.g., cloud deployment)?
- Are there any partnerships or integrations with research institutions, journals, or repositories?
- How does ReClaim handle large-scale or multi-institutional projects?
- What are the plans for incorporating feedback from actual users?
- Is there a roadmap for monetization or commercialization?
Investment/Partnership Verdict
Not evidenced.
There is no evidence of revenue, customers, traction, or commercial viability beyond the author’s own development and demonstration. The tool appears to be a prototype with no indication of market demand or product-market fit.
The project is self-reported, unverified, and lacks any commercial due-diligence signals. It cannot be evaluated for investment or partnership potential without further evidence of adoption, traction, or scalability.
Source
Submitted to the OpenAI 2026 hackathon on Devpost. Project home on DevPost.
The analysis above was generated by a language model from the project's own one-line description. It is not independent research and contains no verified traction, revenue or customer data.
